Winst gevend schreef op 15 april 2024 14:33:
.
NHI - National Library of Medicine
National Center for Biotechnology Information.
Leniolisib als mogelijke vervanger van Antibiotica.
While satisfaction with available treatment options was mixed, ranging from very low to high satisfaction,
physicians who had already used leniolisib were satisfied with its disease-modulating activity and safety.
One respondent reported safety and tolerability issues with prednisolone (arterial hypertension, kidney insufficiency, osteonecrosis) and cyclosporin (infections).
The other respondents reported acceptable to good tolerability of the chosen treatment options,
including rapamycin and leniolisib.
Several respondents reported being able to discontinue other medications (e.g., antibiotics)
in their patient after starting therapy with leniolisib.
Toch wel een hele bijzondere toevoeging van dit gerenomeerd instutuut, richting leniolisib (joenja)
Fijne dag verder.